Robert W. Baird Keeps Their Hold Rating on Varian Medical Systems

By Ryan Adsit

Robert W. Baird analyst Jeff Johnson reiterated a Hold rating on Varian Medical Systems (NYSE: VAR) today and set a price target of $99. The company’s shares closed on Friday at $101.99, close to its 52-week high of $107.08.

According to TipRanks.com, Johnson is a 4-star analyst with an average return of 7.1% and a 60.8% success rate. Johnson covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Wright Medical Group, and DENTSPLY SIRONA Inc.

Varian Medical Systems has an analyst consensus of Moderate Buy, with a price target consensus of $103.

The company has a one year high of $107.08 and a one year low of $75.23. Currently, Varian Medical Systems has an average volume of 809.2K.

Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical condition. It operates through the Oncology Systems and Imaging Components segments.